EUVIMEDEUVIMED entdecken
Crossref

Fabrication and production of conjugated neurotensin–silver nanoparticles and evaluation of its effect on pathophysiology of allergic asthma

Yu Yang, Entezar Mehrabi Nasab, Seyyed Shamsadin Athari

Allergologia et Immunopathologia · 2025

DOI: 10.15586/aei.v53i5.1391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2025. Verfasst von Yu Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009, China. Hauptthemen laut MEDLINE: Asthma, Neurotensin, Silver, Metal Nanoparticles. Gefördert von: Not Applicable..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma, a respiratory tract disease, is characterized by inflammation and obstruction of airway. Inflammatory cells play a significant role in allergic asthma, and there is no complete cure for asthma. One of the new approaches in medicines is nanoparticle-base treatment. The aim of the current study is to introduce a new therapeutic approach in nano-medicine with neurotensin. Conjugated peptide nanoparticles were prepared and characterized, and then administrated to asthmatic mice. Airway hyperresponsiveness (AHR) test, broncho-alveolar lavage fluid (BALF) cells counting, cytokines level, and histopathology study were conducted. Treatment with peptide nanoparticles could control AHR, percentage of eosinophils in BALF, levels of interleukin 4 (IL-4), IL-5, and IL-33, peri-airways and perivascular eosinophilic inflammation. Producing and using of new peptide nano-drugs could introduce new therapeutic approach in controlling pathological-related mechanisms in allergic asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaNeurotensinSilverMetal NanoparticlesAnimalsMiceBronchoalveolar Lavage FluidCytokinesMice, Inbred BALB CHumansDisease Models, AnimalEosinophilsFemale

Stichwörter der Autor:innen

allergyinflammationlungnanoparticle

Substanzen

NeurotensinSilverCytokines

Autor:innen und Institutionen

  • Department of Respiratory, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009, China.
  • Department of Cardiology, School of Medicine, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran; ss.athari@zums.ac.ir; ss.athari@gmail.com.

Förderung

  • Not Applicable.

Zitieren

APA

Yang, Y., Nasab, E. M., & Athari, S. S. (2025). Fabrication and production of conjugated neurotensin–silver nanoparticles and evaluation of its effect on pathophysiology of allergic asthma. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v53i5.1391

Vancouver

Yang Y, Nasab EM, Athari SS. Fabrication and production of conjugated neurotensin–silver nanoparticles and evaluation of its effect on pathophysiology of allergic asthma. Allergologia et Immunopathologia. 2025. doi:10.15586/aei.v53i5.1391

BibTeX
@article{Yang2025,
  author = {Yang, Yu and Nasab, Entezar Mehrabi and Athari, Seyyed Shamsadin},
  title = {Fabrication and production of conjugated neurotensin–silver nanoparticles and evaluation of its effect on pathophysiology of allergic asthma},
  journal = {Allergologia et Immunopathologia},
  year = {2025},
  doi = {10.15586/aei.v53i5.1391}
}
Kostenlos starten →